DrugSafetyJ Profile Banner
Nitin Joshi Profile
Nitin Joshi

@DrugSafetyJ

Followers
1K
Following
524
Statuses
448

Editor-in-Chief of ๐˜ฟ๐™ง๐™ช๐™œ ๐™Ž๐™–๐™›๐™š๐™ฉ๐™ฎ, the official journal of the International Society of Pharmacovigilance (@ISoPonline). All views are my own.

New Zealand
Joined March 2010
Don't wanna be here? Send us removal request.
@DrugSafetyJ
Nitin Joshi
3 months
Our paper on Paper Mills now published in @PLOSBiology #OpenAccess #ResearchIntegrity #PaperMills
@JAByrneSci
Prof Jennifer Byrne ๐Ÿงฌ
3 months
"A call for research to address the threat of paper mills" 5 key questions that need resourcing & support Proof: ๐Ÿ’™ @AbalkinaAnna @Image_Integrity @DrSarahEaton @nickwizzo @JennWrights #United2Act co-authors & members @C0PE @STMAssoc @PLOSBiology
0
1
0
@DrugSafetyJ
Nitin Joshi
4 months
๐Ÿ‘‰๐™‹๐™š๐™ฃ๐™˜๐™ž๐™ก ๐™ž๐™ฃ ๐™ฉ๐™๐™š ๐™™๐™–๐™ฉ๐™š - ๐—ง๐—ต๐˜‚๐—ฟ๐˜€๐—ฑ๐—ฎ๐˜† 7 ๐—ก๐—ผ๐˜ƒ๐—ฒ๐—บ๐—ฏ๐—ฒ๐—ฟ 2024 ๐—ฎ๐˜ 09:00 ๐—จ๐—ง๐—– @ISoPonline members - Listen to the authors of the ๐—ฅ๐—˜๐—”๐——๐—จ๐—ฆ-๐—ฃ๐—ฉ ๐—š๐˜‚๐—ถ๐—ฑ๐—ฒ๐—น๐—ถ๐—ป๐—ฒ๐˜€ ๐Ÿ‘‰The presentation will be followed by a Q&A session
Tweet media one
0
0
2
@DrugSafetyJ
Nitin Joshi
4 months
@montastrucf I am glad you liked it @montastrucf
0
0
0
@DrugSafetyJ
Nitin Joshi
4 months
I am truly honoured and grateful to be admitted as a Fellow of the International Society of Pharmacovigilance (FISoP), recognising my contributions to the discipline of pharmacovigilance and my service to @ISoPonline #ISoP2024Montreal #ISoPFellow #Pharmacovigilance #DrugSafety
Tweet media one
Tweet media two
Tweet media three
0
1
9
@DrugSafetyJ
Nitin Joshi
4 months
๐Ÿ“ข Excited to announce the newest addition to our ๐˜ฟ๐™ง๐™ช๐™œ ๐™Ž๐™–๐™›๐™š๐™ฉ๐™ฎ family - a heartfelt welcome to Professor Nicole Pratt (@nicolepratt_ @UniversitySA), who has joined the Editorial Board of ๐˜ฟ๐™ง๐™ช๐™œ ๐™Ž๐™–๐™›๐™š๐™ฉ๐™ฎ. ๐Ÿš€ #NewBeginnings #DrugSafetyCommunity #Pharmacovigilance
0
0
1
@DrugSafetyJ
Nitin Joshi
5 months
๐Ÿ‘‰๐Ÿป ๐—ฆ๐—ฒ๐—ฒ ๐˜†๐—ผ๐˜‚ ๐—ป๐—ฒ๐˜…๐˜ ๐˜„๐—ฒ๐—ฒ๐—ธ ๐—ถ๐—ป ๐— ๐—ผ๐—ป๐˜๐—ฟ๐—ฒ๐—ฎ๐—น #ISoP2024Montreal #Pharmacovigilance
Tweet media one
0
0
1
@DrugSafetyJ
Nitin Joshi
5 months
๐Ÿ“ข Thrilled to announce the newest addition to our ๐˜ฟ๐™ง๐™ช๐™œ ๐™Ž๐™–๐™›๐™š๐™ฉ๐™ฎ family - a heartfelt welcome to Dr Florence van Hunsel (@Lareb_NL), who has joined the Editorial Board of ๐˜ฟ๐™ง๐™ช๐™œ ๐™Ž๐™–๐™›๐™š๐™ฉ๐™ฎ #NewBeginnings #DrugSafetyCommunity #Pharmacovigilance
Tweet media one
0
0
1
@DrugSafetyJ
Nitin Joshi
5 months
๐˜—๐˜ข๐˜ณ๐˜ข๐˜ค๐˜ฆ๐˜ต๐˜ข๐˜ฎ๐˜ฐ๐˜ญ ๐˜ฅ๐˜ฐ๐˜ด๐˜ช๐˜ฏ๐˜จ ๐˜ฆ๐˜ณ๐˜ณ๐˜ฐ๐˜ณ๐˜ด ๐˜ค๐˜ฐ๐˜ฏ๐˜ต๐˜ช๐˜ฏ๐˜ถ๐˜ฆ ๐˜ต๐˜ฐ ๐˜ฐ๐˜ค๐˜ค๐˜ถ๐˜ณ, ๐˜ธ๐˜ช๐˜ต๐˜ฉ ๐˜ณ๐˜ฆ๐˜ญ๐˜ข๐˜ต๐˜ช๐˜ท๐˜ฆ๐˜ญ๐˜บ ๐˜ฉ๐˜ช๐˜จ๐˜ฉ ๐˜ณ๐˜ข๐˜ต๐˜ฆ๐˜ด ๐˜ฐ๐˜ง ๐˜ฉ๐˜ฐ๐˜ด๐˜ฑ๐˜ช๐˜ต๐˜ข๐˜ญ๐˜ช๐˜ด๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ข๐˜ฏ๐˜ฅ ๐˜ญ๐˜ช๐˜ท๐˜ฆ๐˜ณ ๐˜ช๐˜ฏ๐˜ซ๐˜ถ๐˜ณ๐˜บ #OpenAccess #Pharmacovigilance #Paracetamol
Tweet media one
0
2
0
@DrugSafetyJ
Nitin Joshi
5 months
๐Ÿ“ขLooking forward to attending the 23 Annual Meeting of the @ISoPonline in Montreal. I will be conducting a Meet-the-Editor session on 04 Oct. Bring along all your publishing queries. Letโ€™s have an engaging discussion. See you there!โœจ #ISoP2024Montreal
Tweet media one
0
1
6
@DrugSafetyJ
Nitin Joshi
7 months
๐—–๐—ข๐—ฉ๐—œ๐——-19 ๐—ฉ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฒ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—”๐—ฐ๐˜‚๐˜๐—ฒ ๐—”๐—ฝ๐—ฝ๐—ฒ๐—ป๐—ฑ๐—ถ๐—ฐ๐—ถ๐˜๐—ถ๐˜€ Data from Italy showed ๐—ก๐—ผ ๐—”๐˜€๐˜€๐—ผ๐—ฐ๐—ถ๐—ฎ๐˜๐—ถ๐—ผ๐—ป between COVID-19 vaccines (BNT162b, ChAdOx1-S, mRNA-1273 and Ad26.COV2-S) and acute appendicitis. #OpenAccess #Covid19Vaccines
Tweet media one
0
0
0
@DrugSafetyJ
Nitin Joshi
7 months
Now published: our second review article in the Q&A format #OpenAccess #Pharmacovigilance
Tweet media one
0
1
3
@DrugSafetyJ
Nitin Joshi
8 months
๐Ÿ‘‰ From ๐——๐—ฟ๐˜‚๐—ด ๐—ฆ๐—ฎ๐—ณ๐—ฒ๐˜๐˜† archives ๐—ง๐—ต๐—ฒ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐——๐—ถ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ณ๐—ผ๐—ฟ ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—”๐—ฐ๐˜๐—ถ๐˜ƒ๐—ถ๐˜๐—ถ๐—ฒ๐˜€ (๐— ๐—ฒ๐—ฑ๐——๐—ฅ๐—”) Full Link
Tweet media one
0
0
5
@DrugSafetyJ
Nitin Joshi
9 months
Not Just Another Reporting Guideline? Hereโ€™s Why READUS-PV is a Major Step Forward Read this commentary for free by our Editorial Board member Professor Yoon Loke University of East Anglia) #Pharmacovigilance
0
1
3
@DrugSafetyJ
Nitin Joshi
9 months
๐Ÿ‘‰ Just published The READUS-PV guidelines on the Reporting of a Disproportionality Analysis for Drug Safety Signal Detection #OpenAcess #Pharmacovigilance
Tweet media one
Tweet media two
0
6
9
@DrugSafetyJ
Nitin Joshi
11 months
RT @ISoPonline: Another successful PV Journal club in the books! ๐Ÿ“š With 43 engaged participants, huge thanks to Nitin Joshi and Rebecca Chaโ€ฆ
0
1
0
@DrugSafetyJ
Nitin Joshi
11 months
๐—ฃ๐—ฒ๐—ฒ๐—ฟ ๐—ฅ๐—ฒ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐—ถ๐—ป ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐˜ƒ๐—ถ๐—ด๐—ถ๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ: ๐—Ÿ๐—ฒ๐—ป๐˜€ ๐—ผ๐—ป ๐——๐—ถ๐˜€๐—ฝ๐—ฟ๐—ผ๐—ฝ๐—ผ๐—ฟ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€ It was an excellent experience to work together on this subject alongside some of the leading experts in the field
Tweet media one
0
4
9
@DrugSafetyJ
Nitin Joshi
11 months
๐Ÿ‘‰The Critical Role of Regulations in Pharmacovigilance ๐Ÿ‘‰Guest edited by Kenneth Hartigan-Go and Raymond Chua, this collection highlights the indispensable intersect between health regulations and the discipline of pharmacovigilance.
Tweet media one
0
0
4
@DrugSafetyJ
Nitin Joshi
1 year
๐Ÿ“ข ๐™„๐™Ž๐™ค๐™‹ ๐™ข๐™š๐™ข๐™—๐™š๐™ง๐™จ - ๐™ง๐™š๐™œ๐™ž๐™จ๐™ฉ๐™š๐™ง ๐™›๐™ค๐™ง ๐™ฉ๐™๐™š ๐™ฃ๐™š๐™ญ๐™ฉ ๐™Ÿ๐™ค๐™ช๐™ง๐™ฃ๐™–๐™ก ๐™˜๐™ก๐™ช๐™— ๐™๐™š๐™ง๐™š โฌ‡๏ธโฌ‡๏ธ Presented by Nele Brusselaers Based on their recent Drug Safety article @ISoPonline #Pharmacovigilance #JournalClub
Tweet media one
0
0
1
@DrugSafetyJ
Nitin Joshi
1 year
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ DILI Initiative Read the full article at #OpenAccess #LiverInjury #DILI
Tweet media one
0
0
0
@DrugSafetyJ
Nitin Joshi
1 year
๐ŸŒŸExciting News! Dr Priya Bahri (EMA) and Pr. Anthony Cox (@Cox_A_R, University of Birmingham) are now part of the Editorial Board of Drug Safety. We extend a warm welcome to both as they become valuable members of the Drug Safety family #NewBeginnings
0
0
5